Publikace












            ******************************************************************************************

            *
            ******************************************************************************************


             
            Pohled do databáze evidence publikační činnosti v systému OBD [ URL "https://obd3.lf3.cuni
            verso.fpl?fname=obd_public&public_id=&public_id=361&_autor_org_podriz=2310"] .


            Ve výpisu jsou záznamy publikací s afiliací k 3. LF UK





            *=========================================================================================
            * Vybrané publikace kliniky
            *=========================================================================================

            • Halaška, Michael J.; Rob, L. a kol.: Onkologická onemocnění během těhotenství. 1.vyd. Pr
              fronta, 2015. 230 s. ISBN 978-80-204-3753-2. Mladá fronta a.s., 2015, ISBN: 978-80-204-3
            • Halaška, Michael J.; Kesić, V.; Rob, L.: 155. Pregnancy and Cancer. In: Ayhan, A.; Reed,

              (Eds.): Textbook of Gynaecological Oncology. 3rd ed. Ankara: Güneş Publishing, 2016, pp.
              978-975-277-645-6.
            • Halaška, Michael; Rob, L.: Komplikace v urogynekologii. In: Halaška, M. et al.: Urogynek

              Praha: Galén, 2004, s. 157-161. ISBN 80-7262-272-2.
            • Halaška, Michael J. (K); Nováčková, M.; Malá, I.; Pluta, M.; Chmel, R.; Stankušová, H.; 
              L.: A Prospective Study of Postoperative Lymphedema After Surgery for Cervical Cancer. I

              Journal of Gynecological Cancer, 2010, 20(5): 900-904. DOI: 10.1111/IGC.0b013e3181da29d0
              1.558/2010; Aktuální IF časopisu: 2.369/2016
            • Halaška, Michael J. (K); Rob, L.; Robová, H.; Černý, M.: Treatment of gynecological canc

              during pregnancy. Future Oncology, 2016, 12(19): 2265-2275. DOI: 10.2217/fon-2016-0271. 
              2.131/2016
            • Rob L, Halaška M, Robová H: Nerve-sparing and individually tailored surgery for cervical

              Lancet Oncol 2010; 11: 292-301
            • Rob L, Pluta M, Robová H: Less radical surgery than radical hysterectomy in early stage 
              Gynecol Oncol 2010; 117(1): 148

            • Rob L, Pluta M, Škapa P, Robová H: Advanced in fertility-sparing surgery for cervical ca
              anticancer Ther 2010;10(7): 1101-1114
            • Robová H, Halaska M, Pluta M, Skapa P, Strnad P, Lisý J, Rob L: The role of neoadjuvant 

              surgery in cervical cancer. Int J Gynecol Cancer 2010; 20, 42-46
            • Rob L, Šlapa P, Robová H: Fertility- sparing surgery in patiens with cervical cancer. Th
              2011; 12, 192-200

            • Fučíková J, Králíková P, Fialová A, Brtnický T, Rob L, Bartůňková J, Špíšek R: Human tum
              by anthracyclines induce a tumor-specific immune response. Cancer Research 2011; 71(14):
            • Rob L, Robova H, Chmel R, Komar M, Halaska M, Skapa P. Surgical options in early cervica

              Hyperthermia. 2012;28(6):489-500
            • Robova H, Rob L, Halaska MJ, Pluta M, Skapa P, Strnad P, Lisy J, Komar M. High-dose dens
              chemotherapy in bulky IB cervical cancer. Gynecol Oncol. 2013, Jan, 128(1):49-53

            • Robova H, Rob L, Halaska MJ, Pluta M, Skapa P. Current status of sentinel lymph node map
              management of endometrial cancer. Expert Rev Anticancer Ther.2013,13(1):55-61
            • Rob L, Robova H, Halaska MJ, Hruda M, Skapa P. Current status of sentinel lymph node map

              management of cervical cancer. Expert Rev Anticancer Ther.2013,13(7):861-870
            • Halaska MJ, Komar M, Vlk R, Tomek V, Skultety J, Robova H, Rob L. A pilot study on peak 
              velocity monitoring of fetal anemia after administration of chemotherapy during pregnanc

              Gynecol Reprod Biol. 2014, 174, 76-79
            • Robova H, Halaska MJ, Pluta M, Skapa P, Matecha J, Lisy J, Rob L. Oncological and pregna
              after high-dose density neoadjuvatnt chemotherapy and fertility-sparing surgery in cervi

              Gynecol Oncol, 2014, 135(2): 213-216
            • Fucikova J, Moserova I, Truxova I, Hermanova I, Vancurova I, Partlova S, Fialova A, Sojk
              PF, Houska M, Rob L, Bartunkova J, Spisek R. High hydrostatic pressure induces immunogen

              human tumor cells. Int J Cancer. 2014 Sep 1;135(5):1165-77.
            • Rob L, Robova H, Pluta M, Halaska MJ, Matecha J, Skapa P. Less radical surgery than radi
              trachelectomy or radical hysterectomy in patients with stage I cervical cancer. Gynecol 

              133: 66-67
            • Robova H, Rob L, Halaska MJ, Pluta M, Skapa P. Review of Neoadjuvant Chemotherapy and Tr
              Which Cervical Cancer Patients Would Be Suitable for Neoadjuvant Chemotherapy Followed b

              Sparing Surgery? Current Oncology Reports 2015, 17(5), 446-500
            • Amant, F.; Vandenbroucke, T.; Verheecke, M.; Fumagalli, M.; Halaska, M. J.; Boere, I.; H
              M. M.; Peccatori, F.; Rob, L.; Lok, C.; Witteveen, P.; Voigt, J-U; Naulaers, G.; Vallaey

              Heuvel, F.; Lagae, L.; Mertens, L.; Claes, L.; Van Calsteren, K. Pediatric Outcome after
              Diagnosed during Pregnancy, N Engl J Med 2015; 373: 1824-34
            • Halaska MJ, Rob L, Robova H., Cerny M.. Treatment of gynecological cancer diagnosed duri

              Future Oncol 2016, 12(19):2265-75